DOI QR코드

DOI QR Code

막성사구체신염과 동반된 폐포단백증 1예

Concurrence of Membranous Glomerulonephritis and Pulmonary Alveolar Proteinosis

  • 박봉수 (인제대학교 의과대학 해운대백병원 내과) ;
  • 김양욱 (인제대학교 의과대학 해운대백병원 내과) ;
  • 김현국 (인제대학교 의과대학 해운대백병원 내과) ;
  • 노태훈 (인제대학교 의과대학 해운대백병원 내과) ;
  • 서민교 (인제대학교 의과대학 해운대백병원 내과) ;
  • 김연미 (인제대학교 의과대학 해운대백병원 병리과) ;
  • 진규복 (인제대학교 의과대학 해운대백병원 내과)
  • Park, Bongsoo (Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine) ;
  • Kim, Yang Wook (Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine) ;
  • Kim, Hyunkuk (Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine) ;
  • No, Taehoon (Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine) ;
  • Seo, Mingyo (Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine) ;
  • Kim, Yeon Mee (Department of Pathology, Haeundae Paik Hospital, Inje University College of Medicine) ;
  • Jin, Kyubok (Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine)
  • 투고 : 2013.08.16
  • 심사 : 2013.12.23
  • 발행 : 2014.08.01

초록

막성사구체신염 및 폐포단백증의 발생에는 자가면역 기전이 중요한 역할을 하는 것으로 알려져 있다. 우연히 동시에 두 질환이 발생하였는지 혹은 공통된 자가항체를 가지는 지는 명확하지 않다. 이에 대한 더 많은 증례보고와 추가적인 연구가 필요할 것으로 생각된다.

Membranous glomerulonephritis is one of the most common causes of nephrotic syndrome in adults. Pulmonary alveolar proteinosis (PAP) is a rare lung disease in which abnormal accumulation of surfactant occurs within the alveoli. We describe a 61-year-old man with concurrent membranous glomerulonephritis and PAP, which is very rare; both are pathophysiologically related to an abnormal immune response. A patient came to hospital with leg edema but no respiratory symptoms. Chest X-ray and CT showed classical PAP findings, which are ground-glass opacities with interlobular septal thickening, in both lung fields. A bubbly whitish secretion retrieved via broncho-alveolar lavage showed neutrophils and lymphocytes as well as Periodic acid-Schiff-positive proteinaceous materials. A kidney biopsy revealed findings of membranous glomerulonephritis with irregular subepithelial deposits by electron microscopy. At 1 year after diagnosis, the membranous glomerulonephritis was well under control with steroids and mycophenolate mofetil but PAP became aggravated gradually and whole-lung lavage was needed.

키워드

참고문헌

  1. Beck LH Jr, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009;361:11-21. https://doi.org/10.1056/NEJMoa0810457
  2. Nogee LM, de Mello DE, Dehner LP, Colten HR. Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N Engl J Med 1993;328:406-410. https://doi.org/10.1056/NEJM199302113280606
  3. Kitamura T, Tanaka N, Watanabe J, et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med 1999;190:875-880. https://doi.org/10.1084/jem.190.6.875
  4. Yamada H, Miura N, Kitagawa W, et al. Membranous nephropathy and pulmonary alveolar proteinosis. Intern Med 2007;46:1441-1446. https://doi.org/10.2169/internalmedicine.46.0129
  5. Ronco P, Debiec H. Antigen identification in membranous nephropathy moves toward targeted monitoring and new therapy. J Am Soc Nephrol 2010;21:564-569. https://doi.org/10.1681/ASN.2009121220
  6. Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med 2002;166:215-235. https://doi.org/10.1164/rccm.2109105
  7. Tazawa R, Trapnell BC, Inoue Y, et al. Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2010;181:1345-1354. https://doi.org/10.1164/rccm.200906-0978OC